Top Stories
Top Stories
Health and Science

US tells cannabis companies not to advertise disease treatments without science

Key Points
  • A U.S. consumer and trade regulator is warning cannabis companies against making unproven health claims.
  • CBD, the chemical derived from the cannabis plant, has been touted as alleviating countless physical ailments.
  • The regulator said its illegal to advertise that cannabis products could fight disease without providing credible scientific evidence.
A customer holding a cannabis product gestures while leaving the Natural Vibe store after legal recreational marijuana went on sale in St John's, Newfoundland and Labrador, Canada October 17, 2018. 
Chris Wattie | Reuters

The top U.S. consumer and trade regulator said on Tuesday it had warned three companies selling products infused with cannabidiol that it was illegal to advertise that such products could fight disease without providing credible scientific evidence.

In recent years, the chemical derived from the cannabis plant, commonly called CBD, has been touted as alleviating countless physical ailments.

The Federal Trade Commission said the three unidentified companies claimed, without providing substantiation, that CBD can treat more than two dozen conditions including cancer, Alzheimer's, multiple sclerosis, schizophrenia, epilepsy, diabetes, psoriasis, and AIDS.

The companies, which sell oils, tinctures, capsules, gummies and creams, have 15 days to inform the FTC about how they will address the warning.